过去20天，关于新型冠状病毒已经发表了50多篇论文，科学家们急于理解这一病原体以及它是怎样传播的。

新型冠状病毒，也称作2019-nCoV，导致了严重的呼吸道疾病，目前已感染并致死多人，并已扩散至多国。

Nature用新冠病毒相关关键词搜索了bioRxiv, medRxiv等学术网站，截止1月30日，至少有50篇新冠病毒英文论文发表，超过一半在过去7天发表。

超过30篇发表在预印本服务器，部分发表在同行评议期刊上，包括《柳叶刀》和《病毒学杂志》。该统计未包括中文杂志。

其中几篇论文预测了该病毒的传播速度，以及它的潜伏期。其他论文聚焦于该病毒的结构和基因构成，这一信息有助于鉴别出药物靶点和开发相关疫苗。

另外，研究人员还在GISAID、GenBank等平台公布了病毒基因组数据，不过这些未统计在内。

https://www.nature.com/articles/d41586-020-00253-8

以下为论文列表（未完全统计）

1 Offline: 2019-nCoV outbreak—early lessons

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30212-9/fulltext

2 Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30211-7/fulltext#

3 Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30251-8/fulltext

4 A novel coronavirus outbreak of global health concern

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30185-9/fulltext

5 Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30183-5/fulltext

6 A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30154-9/fulltext

7 Emerging understandings of 2019-nCoV

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)30186-0/fulltext

8 Coronavirus Infections—More Than Just the Common Cold

https://jamanetwork.com/journals/jama/fullarticle/2759815

9 The Novel Coronavirus Originating in Wuhan, China Challenges for Global Health Governance

https://jamanetwork.com/journals/jama/fullarticle/2760500

10 Transmission of 2019-nCoV Infection from an Asymptomatic Contact in Germany

https://www.nejm.org/doi/full/10.1056/NEJMc2001468?query=featured_coronavirus

11 Importation and Human-to-Human Transmission of a Novel Coronavirus in Vietnam

https://www.nejm.org/doi/full/10.1056/NEJMc2001272?query=featured_coronavirus

12 Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia

https://www.nejm.org/doi/full/10.1056/NEJMoa2001316?query=featured_coronavirus

13 A Novel Coronavirus Emerging in China — Key Questions for Impact Assessment

https://www.nejm.org/doi/full/10.1056/NEJMp2000929?query=featured_coronavirus

14 A Novel Coronavirus from Patients with Pneumonia in China, 2019

https://www.nejm.org/doi/full/10.1056/NEJMoa2001017?query=featured_coronavirus

15 The psychological effects of quarantining a city

https://www.bmj.com/content/368/bmj.m313

16 Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross‐species transmission from snake to human

https://onlinelibrary.wiley.com/doi/abs/10.1002/jmv.25682

17 Following the evidence, from coronavirus to terrorism response

https://www.bmj.com/content/368/bmj.m344

18 The 2019‐new coronavirus epidemic: evidence for virus evolution

https://onlinelibrary.wiley.com/doi/10.1002/jmv.25688

19 Coronavirus Infections and Immune Responses

https://onlinelibrary.wiley.com/doi/10.1002/jmv.25685

20 Updated understanding of the outbreak of 2019 novel coronavirus (2019‐nCoV) in Wuhan, China

https://onlinelibrary.wiley.com/doi/10.1002/jmv.25689

21 Homologous recombination within the spike glycoprotein of the newly identified coronavirus may boost cross‐species transmission from snake to human

https://onlinelibrary.wiley.com/doi/10.1002/jmv.25682

22 Emerging coronaviruses: genome structure, replication, and pathogenesis

https://onlinelibrary.wiley.com/doi/10.1002/jmv.25681

23 Outbreak of Pneumonia of Unknown Etiology in Wuhan China: the Mystery and the Miracle

https://onlinelibrary.wiley.com/doi/10.1002/jmv.25678

24 Potential of large ‘first generation’ human‐to‐human transmission of 2019‐nCoV

https://onlinelibrary.wiley.com/doi/10.1002/jmv.25693

25 Receptor recognition by novel coronavirus from Wuhan: An analysis based on decade-long structural studies of SARS

https://jvi.asm.org/content/early/2020/01/23/JVI.00127-20

预印本

1 Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

https://www.biorxiv.org/content/10.1101/2020.01.28.923011v1

2 Origin time and epidemic dynamics of the 2019 novel coronavirus

https://www.biorxiv.org/content/10.1101/2020.01.25.919688v2

3 Transmission dynamics of 2019 novel coronavirus (2019-nCoV)

https://www.biorxiv.org/content/10.1101/2020.01.25.919787v1

4 The 2019-new coronavirus epidemic: evidence for virus evolution

https://www.biorxiv.org/content/10.1101/2020.01.24.915157v1

5 Potential inhibitors for 2019-nCoV coronavirus M protease from clinically approved medicines

https://www.biorxiv.org/content/10.1101/2020.01.29.924100v1

6 Modelling the epidemic trend of the 2019 novel coronavirus outbreak in China

https://www.biorxiv.org/content/10.1101/2020.01.23.916726v1

7 2019-20 Wuhan coronavirus outbreak: Intense surveillance is vital for preventing sustained transmission in new locations

https://www.biorxiv.org/content/10.1101/2020.01.24.919159v1

8 Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China

https://www.biorxiv.org/content/10.1101/2020.01.24.919183v1

9 Host and infectivity prediction of Wuhan 2019 novel coronavirus using deep learning algorithm

https://www.biorxiv.org/content/10.1101/2020.01.21.914044v2

10 A mathematical model for simulating the transmission of Wuhan novel Coronavirus

https://www.biorxiv.org/content/10.1101/2020.01.19.911669v1

11 Insights into Cross-species Evolution of Novel Human Coronavirus 2019-nCoV and Defining Immune Determinants for Vaccine Development

https://www.biorxiv.org/content/10.1101/2020.01.29.925867v1

12 Breaking down of healthcare system: Mathematical modelling for controlling the novel coronavirus (2019-nCoV) outbreak in Wuhan, China

https://www.biorxiv.org/content/10.1101/2020.01.27.922443v2

13 Discovery of a novel coronavirus associated with the recent pneumonia outbreak in humans and its potential bat origin

https://www.biorxiv.org/content/10.1101/2020.01.22.914952v2

14 Genomic and protein structure modelling analysis depicts the origin and infectivity of 2019-nCoV, a new coronavirus which caused a pneumonia outbreak in Wuhan, China

https://www.biorxiv.org/content/10.1101/2020.01.20.913368v2

15 Preliminary estimation of the basic reproduction number of novel coronavirus (2019-nCoV) in China, from 2019 to 2020: A data-driven analysis in the early phase of the outbreak

https://www.biorxiv.org/content/10.1101/2020.01.23.916395v2

16 Pattern of early human-to-human transmission of Wuhan 2019-nCoV

https://www.biorxiv.org/content/10.1101/2020.01.23.917351v1

17 Therapeutic Drugs Targeting 2019-nCoV Main Protease by High-Throughput Screening

https://www.biorxiv.org/content/10.1101/2020.01.28.922922v2

18 Beware of asymptomatic transmission: Study on 2019-nCoV prevention and control measures based on extended SEIR model

https://www.biorxiv.org/content/10.1101/2020.01.28.923169v1

19 Nelfinavir was predicted to be a potential inhibitor of 2019-nCov main protease by an integrative approach combining homology modelling, molecular docking and binding free energy calculation

https://www.biorxiv.org/content/10.1101/2020.01.27.921627v1

20 Risk of 2019 novel coronavirus importations throughout China prior to the Wuhan quarantine

https://www.medrxiv.org/content/10.1101/2020.01.28.20019299v1

21 Estimated effectiveness of traveller screening to prevent international spread of 2019 novel coronavirus (2019-nCoV)

https://www.medrxiv.org/content/10.1101/2020.01.28.20019224v1

22 Novel coronavirus 2019-nCoV: early estimation of epidemiological parameters and epidemic predictions

https://www.medrxiv.org/content/10.1101/2020.01.23.20018549v2

23 Epidemiological characteristics of novel coronavirus infection: A statistical analysis of publicly available case data

https://www.medrxiv.org/content/10.1101/2020.01.26.20018754v1

24 Estimating the effective reproduction number of the 2019-nCoV in China

https://www.medrxiv.org/content/10.1101/2020.01.27.20018952v1

25 The incubation period of 2019-nCoV infections among travellers from Wuhan, China

https://www.medrxiv.org/content/10.1101/2020.01.27.20018986v2

26 Epidemiological identification of a novel infectious disease in real time: Analysis of the atypical pneumonia outbreak in Wuhan, China, 2019-20

https://www.medrxiv.org/content/10.1101/2020.01.26.20018887v1

27 Learning from the Past: Possible Urgent Prevention and Treatment Options for Severe Acute Respiratory Infections Caused by 2019-nCoV

https://chemrxiv.org/articles/Learning_from_the_Past_Possible_Urgent_Prevention_and_Treatment_Options_for_Severe_Acute_Respiratory_Infections_Caused_by_2019-nCoV/11728983

28 Homology Models of Wuhan Coronavirus 3CLpro Protease

https://chemrxiv.org/articles/Homology_Models_of_Wuhan_Coronavirus_3CLpro_Protease/11637294